Item
Manganese Gluconate Dihydrate (20496)
Food Ingredient
Locations
Location name | Address |
---|---|
Tomita Pharmaceutical Co., Ltd. | 85-1, Maruyama, Akinokami, Seto-cho Naruto, 36 7710360 JPN |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
CoA Sample | Tomita Pharmaceutical Co., Ltd. | _Control COA 20496-50582 - Manganese Gluconate Dihydrate R11-21 (ID 1941965).pdf | 4/21/2025 | 4/21/2027 |
Safety Data Sheet (SDS) | Tomita Pharmaceutical Co., Ltd. | 20426 Safety Data Sheet (SDS) R9-24 (ID 3162549).pdf | 3/19/2025 | 3/18/2028 |
HACCP Process Flow Diagram | Tomita Pharmaceutical Co., Ltd. | 20496 Flow Chart R5-20 (ID 2201604).pdf | 12/14/2023 | 12/13/2025 |
HACCP | Tomita Pharmaceutical Co., Ltd. | 20496 Flow Chart R5-20 (ID 2201604).pdf | 11/5/2024 | 11/5/2027 |
HARPC Food Safety Plan (Item) | Tomita Pharmaceutical Co., Ltd. | 20496 Flow Chart R5-20 (ID 2201604).pdf | 11/5/2024 | 11/5/2027 |
Gluten | Tomita Pharmaceutical Co., Ltd. | 20496 Gluten D8-22 (ID 2331770).pdf | 12/6/2024 | 12/6/2026 |
GMO | Tomita Pharmaceutical Co., Ltd. | 20496 GMO D12-19 R12-19 (ID 2201605).pdf | 11/3/2022 | 11/2/2024 |
GRAS/NDI/ODI Statement | Tomita Pharmaceutical Co., Ltd. | 20496 GRAS Status D8-22 R8-22 (ID 2336668).pdf | 9/21/2023 | 9/20/2026 |
EtO Statement | Tomita Pharmaceutical Co., Ltd. | 20496 Irradiation; ETO D8-22 R8-22 (ID 2201609).pdf | 8/26/2022 | 8/26/2023 |
Irradiation Status Statement | Tomita Pharmaceutical Co., Ltd. | 20496 Irradiation; ETO D8-22 R8-22 (ID 2201609).pdf | 12/6/2024 | 12/6/2026 |
Residual Statement | Tomita Pharmaceutical Co., Ltd. | 20496 Residual Solvents D5-20 R5-20 (ID 2201619).pdf | 11/3/2022 | 11/3/2023 |
Ingredient Statement | Tomita Pharmaceutical Co., Ltd. | 20496 SIDI R10-17 (ID 2201622).pdf | 11/3/2022 | 11/3/2023 |
Sewage Statement | Tomita Pharmaceutical Co., Ltd. | 20496 SIDI R10-17 (ID 2201622).pdf | 11/20/2024 | 11/20/2026 |
Product Specification Sheet | Tomita Pharmaceutical Co., Ltd. | 20496 Specification Sheet D3-19 (ID 2201623).pdf | 8/25/2022 | 8/24/2025 |
California Prop. 65 | Tomita Pharmaceutical Co., Ltd. | 20496 Specification Sheet D3-19 (ID 2201623).pdf | 8/26/2022 | 8/25/2024 |
Vegan/Vegetarian Statement | Tomita Pharmaceutical Co., Ltd. | 20496 Vegan; Vegetarian R1-25 (ID 3312745).pdf | 4/16/2025 | 4/16/2027 |
WADA/NSF/NFL Statement | Tomita Pharmaceutical Co., Ltd. | 20496 WADA D5-20 (ID 2201633).pdf | 11/3/2022 | 11/3/2023 |
Halal | Tomita Pharmaceutical Co., Ltd. | Halal Exp 05-23-24 (Zinc, Mag Gluconate) - Tokushima Plant.pdf | 5/23/2023 | 5/23/2024 |
Kosher | Tomita Pharmaceutical Co., Ltd. | Kosher (Manganese Gluconate) Exp 10-29-24.pdf | 5/23/2023 | 5/23/2024 |
National Bioengineered Food Disclosure Standard (Simplified) | Tomita Pharmaceutical Co., Ltd. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 8/26/2022 | 8/25/2025 |
Allergens | Tomita Pharmaceutical Co., Ltd. | NotApplicable_Allergens.pdf | 4/16/2025 | 4/16/2027 |
Allergens EU/UK | Tomita Pharmaceutical Co., Ltd. | NotApplicable_AllergensEUUK.pdf | 6/21/2024 | 6/21/2026 |
BSE - TSE | Tomita Pharmaceutical Co., Ltd. | NotApplicable_BSETSE.pdf | 8/29/2022 | 8/28/2025 |
Country of Origin | Tomita Pharmaceutical Co., Ltd. | NotApplicable_CountryofOrigin.pdf | 11/3/2022 | 11/2/2025 |
Country of Origin EU/UK | Tomita Pharmaceutical Co., Ltd. | NotApplicable_CountryofOriginEUUK.pdf | 6/21/2024 | 6/21/2027 |
Nutrition | Tomita Pharmaceutical Co., Ltd. | NotApplicable_Nutrition.pdf | 9/13/2022 | 9/12/2025 |
Nutrition EU/UK | Tomita Pharmaceutical Co., Ltd. | NotApplicable_NutritionEUUK.pdf | 6/21/2024 | 6/21/2027 |
Organic | Tomita Pharmaceutical Co., Ltd. | NotApplicable_Organic.pdf | 4/16/2024 | 4/16/2026 |
Pesticide | Tomita Pharmaceutical Co., Ltd. | NotApplicable_Pesticide.pdf | 12/21/2022 | 12/20/2024 |